GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Similar documents
Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Amber Enterprises India Ltd

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Hindustan Media Ventures

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Procter & Gamble Hygiene & Health Care

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

NEUTRAL. Neogen Chemicals Ltd. Issue Open: April 24, 2019 Issue Close: April 26, IPO Note Specialty Chemicals

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Mahindra & Mahindra Ltd.

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Apollo Micro Systems Ltd

GMM Pfaudler Limited BUY. Lining up glassy growth story CMP. `712 Target Price `861. Initiating Coverage Capital goods April 6, 2018

Century Plyboards Ltd

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Future Supply Chain Solutions Ltd

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Transport Corporation of India

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

MISHRA DHATU NIGAM Ltd.

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Newgen Software Technologies Ltd

Varroc Engineering Ltd.

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

Tata Consultancy Services (TCS)

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Aster DM Healthcare Ltd

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

TV Today Network BUY. Go with the market leader. CMP Target Price `297 `363. Initiating Coverage Media. 3-year price chart

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Dr. Reddy s Laboratories

Tech Mahindra ACCUMLATE. Performance Highlights `495 `526. CMP Target Price. 2QFY2018 Result Update IT

Dr Reddy s Laboratories

Dewan Housing Finance

Bajaj Auto ACCUMULATE. Performance Highlights. CMP `2,815 Target Price `3,151. 1QFY2018 Result Update Automobile. 24 July 2017

Aurobindo Pharma ACCUMULATE. Performance Highlights. `780 Target Price CMP `855. 2QFY2019 Result Update Pharmaceutical. Investment Period 12 months

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

Avenue Supermarts Limited

Sandhar Technologies Limited

Bharat Dynamics Ltd SUBSCRIBE. Issue Open: Mar 13, 2018 Issue Close: Mar 15, IPO Note Defence. Key Financials

Simplex Infrastructures

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `440 Target Price. 3QFY2017 Result Update Pharmaceutical. Investment Period -

Prakash Industries BUY. Performance Highlights. CMP Target Price `81 `124. 3QFY2011 Result Update Steel

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,715 Target Price `6,006. 2QFY2017 Result Update Automobile. 3-year price chart

Transcription:

2QFY2019 Result Update Industrial Machinery October 26, 2018 GMM Pfaudler Limited Performance Update Standalone (` cr) Q2FY19 Q2FY18 % yoy Q1FY19 % qoq Net sales 99.2 93.2 29.8% 76.4 6.4% EBITDA 16.0 15.3 37.9% 11.6 4.8% EBITDA margin (%) 16.1% 15.2% 16.4% Adjusted PAT 9.7 7.1 38.0% 7.0 6.7% For Q2FY2019, GMM Pfaudler (GMM) posted a growth of 29.8%/38% yoy growth in revenue/ PAT amid ~94 bps margin expansion. The company is seeing good traction from its user industries like agrochemicals and pharmaceuticals which are seeing robust capex owing to slowdown in China. Healthy order book: Q2 s top-line growth was led by robust execution in all of its segments. While pharma sector share has come down from historical 50% to 30%, the company is seeing good orders from the new Pharma City that is being set up in Hyderabad which has further boosted the company s order book. Specialty chemicals and agro chemicals forms ~60% of H1FY2019 s revenue Margins were decent: Operating margin were robust at 16.1% due to better product mix and cost optimization. GMM is likely to sustain operating margin at ~16-17% level. Its subsidiary is also doing well and likely to maintain robust revenue run rate and margins for the year. Outlook and Valuation: We have increased earnings estimates for improvement in margins and robust order book. We are expecting a CAGR of ~21%/28% in revenue/ earnings over FY18-20E. The stock has given 33% return since our initiation in April and is currently trading at 20x its FY2020 earnings which still looks attractive given its robust earnings growth trajectory. Hence, we recommend BUY with a target price of `1200 (25x FY2020E EPS). Key Financials Y/E March (` cr) FY2016 FY2017 FY2018 FY2019E FY2020E Net Sales 292.1 353.0 405.7 502.8 591.6 % chg -5.1 20.9 14.9 23.9 17.7 Net Profit 19.9 33.3 42.7 58.7 69.0 % chg 6.4 67.0 28.3 37.6 17.5 EBITDA (%) 12.0 13.5 15.3 17.1 17.1 EPS (Rs)* 13.6 22.8 29.2 40.2 47.3 P/E (x) 69.3 41.5 32.3 23.5 20.0 P/BV (x) 8.3 7.1 6.0 4.9 4.1 RoE (%) 11.9 17.1 18.5 21.0 20.4 RoCE (%) 16.1 20.3 22.7 26.9 26.2 EV/EBITDA 37.6 27.3 20.7 14.7 12.1 EV/Sales 4.5 3.7 3.2 2.5 2.1 BUY CMP `945 Target Price `1200 Investment Period 12 Months Stock Info Sector Industrial Machinery Market Cap (` cr) 1,379 Beta 0.9 52 Week High / Low 1200/552 Avg. Daily Volume 3,912 Face Value (`) 2 BSE Sensex 33,690 Nifty 10,056 Reuters Code GMMP.BO Bloomberg Code GMM.IN Shareholding Pattern (%) Promoters 75.0 MF / Banks / Indian Fls 0.3 FII / NRIs / OCBs 1.1 Indian Public / Others 23.6 Abs.(%) 3m 1yr 3yr BSE 200 1.9 11.7 23.9 GMM Pfaudler (9.7) (4.5) 250.0 Nidhi Agrawal 022-39357800 Ext: 6872 nidhi.agrawal@angelbroking.com Source: Company, Angel Research, closing price at the end of 25 Th October 2018 Please refer to important disclosures at the end of this report 1

Exhibit 1: Q2 results at a glance Standalone results -` cr Q2FY18 Q2FY19 YoY % Q1FY19 QoQ % H1FY19 H1FY18 YoY % Net Sales 76.4 99.2 29.8% 93.2 6.4% 192.4 145.3 32.4% As a % of sales Raw Material Consumed 38.0 49.7 30.9% 47.7 4.2% 97.5 69.7 39.8% Stock Adjustment -6.4-1.6-75.6% 2.3-166.4% 0.8-7.5-110.5% Employee Expenses 9.7 10.5 8.2% 9.9 6.3% 20.4 18.3 11.7% Other Expenses 23.5 24.5 4.3% 18.0 36.2% 42.5 45.3-6.3% Total Expenditure 64.8 83.2 28.3% 78.0 6.7% 161.1 125.8 28.1% EBITDA 11.6 16.0 37.9% 15.3 4.8% 31.3 19.5 60.5% Other Income 1.3 1.9 49.4% 1.3 42.1% 3.2 4.1-22.6% Interest 0.1 0.3 145.7% 0.2 100.0% 0.5 0.6-12.5% PBDT 12.7 17.5 37.8% 16.4 6.8% 33.9 23.0 47.5% Depreciation 2.0 2.6 29.5% 2.5 3.4% 5.2 4.0 29.5% PBT 10.7 14.9 39.3% 13.9 7.4% 28.8 19.0 51.2% Tax 3.7 5.2 41.7% 4.8 8.7% 10.0 6.4 54.6% Profit After Tax 7.0 9.7 38.0% 9.1 6.7% 18.8 12.6 49.4% Ratios EBITDA margin 15.2% 16.1% 16.4% 16.0% 16.0% PAT margin % 9.2% 9.8% 9.8% 9.8% 8.7% Tax rate % 34.2% 34.8% 34.4% 34.6% 33.9% Exhibit 2: Segmental performance ` cr Q2FY18 Q2FY19 YoY % Q1FY19 QoQ % H1FY19 H1FY18 YoY % Total Segment Revenue 76.4 99.2 29.8% 93.2 6.4% 192.4 150.5 27.8% Glass Lined Equipments 53.6 67.1 25.2% 65.9 1.7% 133.0 106.5 24.9% Heavy Engineering 9.2 13.7 48.6% 10.4 31.4% 24.1 18.6 29.3% Proprietary Products 13.6 18.4 35.1% 16.9 9.3% 35.3 25.5 38.7% Non GL segment 22.8 32.1 40.6% 27.3 17.7% 59.4 44.1 34.7% As a % of revenue Glass Lined Equipments 70% 68% 71% 69% 71% Heavy Engineering 12% 14% 11% 13% 12% Proprietary Products 18% 19% 18% 18% 17% Non GL segment 30% 32% 29% 31% 29% PBIT 13.1 16.6 26.2% 16.6-0.2% 33.1 22.6 46.8% Glass Lined Equipments 11.6 12.0 3.8% 13.1-8.3% 25.2 19.7 27.8% Heavy Engineering 0.9 2.3 154.6% 2.3 0.9% 4.6 1.7 173.0% Proprietary Products 0.6 2.2 261.3% 1.2 89.3% 3.4 1.2 180.7% Non-GL segment 1.5 4.5 197.4% 3.5 30.6% 8.0 2.9 PBIT margin % 17.2% 16.7% 17.8% 17.2% 15.0% Glass-Lined segment 21.6% 17.9% 19.9% 18.9% 18.5% Heavy Engineering 9.9% 16.9% 22.1% 19.2% 9.1% Proprietary Products 4.5% 12.0% 6.9% 9.5% 4.7% Non-GL segment 6.7% 14.1% 12.7% 13.4% 6.6% Source: Company October 26, 2018 2

Risks to our estimates GMM s primary raw material is steel; any abrupt fluctuation in pricing will adversely impact its profitability. Business may get impacted owing to the inability to get break through with new clients or slowdown in capex by its clients. GMM has market exposure to foreign exchange rates mainly on account of exports, imports and investments in foreign subsidiary, and therefore, it is subjected to the exchange fluctuation risk. October 26, 2018 3

Profit & Loss Statement Y/E March (` cr) FY2016 FY2017 FY2018 FY2019E FY2020E Total operating income 292.1 353.0 405.7 502.8 591.6 % chg -5.1 20.9 14.9 23.9 17.7 Total Expenditure 257.1 305.3 336.7 416.6 490.2 COGS 173.4 209.6 240.9 298.5 351.3 Selling and Administration Expenses 19.2 22.1 23.7 29.3 34.5 Personnel 56.2 66.1 63.5 78.7 92.6 Others Expenses 8.4 7.6 8.7 10.1 11.8 EBITDA 34.9 47.7 69.0 86.2 101.4 % chg -2.8 36.6 44.5 24.9 17.7 (% of Net Sales) 12.0 13.5 17.0 17.1 17.1 Depreciation& Amortisation 8.1 8.2 9.8 10.8 12.7 EBIT 26.8 39.5 59.2 75.4 88.7 % chg 2.7 47.3 49.8 27.4 17.7 (% of Net Sales) 9.2 11.2 14.6 15.0 15.0 Interest & other Charges 0.7 0.9 1.0 1.0 1.0 Other Income 3.6 8.3 9.4 10.8 12.4 (% of Sales) 1.2 2.3 2.3 2.1 2.1 Extraordinary Items - - - - - Share in profit of Associates - - - - - Recurring PBT 29.8 46.9 67.5 85.1 100.1 % chg 5.6 57.4 44.1 26.1 17.5 Tax 9.7 13.6 18.0 26.4 31.0 PAT (reported) 19.9 33.3 42.7 58.7 69.0 % chg 6.4 67.0 28.3 37.6 17.5 (% of Net Sales) 6.8 9.4 10.5 11.7 11.7 Basic & Fully Diluted EPS (Rs) 13.6 22.8 29.2 40.2 47.3 % chg 6.4 67.0 28.3 37.6 17.5 October 26, 2018 4

Consolidated Balance Sheet Y/E March (` cr) FY2016 FY2017 FY2018E FY2019E FY2020E SOURCES OF FUNDS Equity Share Capital 2.9 2.9 2.9 2.9 2.9 Reserves& Surplus 163.9 191.9 227.9 277.5 335.7 Shareholders Funds 166.8 194.8 230.8 280.4 338.6 Minority Interest - - - - - Total Loans - - - - - Other Liab & Prov 4.4 11.1 11.6 12.1 12.8 Total Liabilities 171.3 205.9 242.4 292.5 351.4 APPLICATION OF FUNDS Net Block 53.4 61.2 66.4 70.6 72.9 Capital Work-in-Progress 4.3 2.0 2.0 2.0 2.0 Investments 13.7 44.6 64.6 84.6 94.6 Current Assets 178.6 207.9 233.2 281.7 354.3 Inventories 70.9 82.3 94.5 117.1 137.8 Sundry Debtors 48.7 69.9 80.3 99.5 117.1 Cash 53.6 31.7 30.6 30.7 58.9 Loans & Advances 5.5 24.1 27.7 34.3 40.4 Other Assets - - - - - Current liabilities 84.4 113.2 127.9 151.5 178.3 Net Current Assets 94.2 94.7 105.3 130.2 176.0 Other Non Current Asset 5.6 3.4 4.1 5.0 5.9 October 26, 2018 5

Consolidated Cash flow Statement Y/E March (` cr) FY2016 FY2017 FY2018E FY2019E FY2020E Profit before tax 29.8 46.9 60.7 85.1 100.1 Depreciation 8.1 8.2 9.8 10.8 12.7 Change in Working Capital (2.0) (12.8) (9.7) (24.8) (17.6) Interest / Dividend (Net) - - - - - Direct taxes paid (9.6) (14.0) (18.0) (26.4) (31.0) Others 1.8 5.3 - - - Cash Flow from Operations 24.7 23.0 42.8 44.7 64.2 (Inc.)/ Dec. in Fixed Assets (13.9) (14.4) (15.0) (15.0) (15.0) (Inc.)/ Dec. in Investments 0.3 0.1 - - - Cash Flow from Investing (17.0) (22.0) (36.9) (35.4) (25.5) Issue of Equity - - - - - Inc./(Dec.) in loans - - - - - Others 6.0 6.3 6.7 9.2 10.8 Cash Flow from Financing (6.0) (6.3) (6.7) (9.2) (10.8) Inc./(Dec.) in Cash 1.7 (5.3) (0.8) 0.1 27.9 Opening Cash balances 34.7 36.4 31.1 30.3 30.4 Closing Cash balances 36.4 31.1 30.3 30.4 58.3 Free cash Flow 10.8 8.6 27.8 29.7 49.2 October 26, 2018 6

Key Ratios Y/E March FY16 FY17 FY18E FY19E FY20E Valuation Ratio (x) P/E (on FDEPS) 69.3 41.5 32.3 23.5 20.0 P/CEPS 37.1 24.3 19.1 14.3 12.2 P/BV 8.3 7.1 6.0 4.9 4.1 Dividend yield (%) 0.3 0.4 0.4 0.6 0.7 EV/Sales 4.5 3.7 3.2 2.5 2.1 EV/EBITDA 37.6 27.3 20.7 14.7 12.1 EV / Total Assets 7.7 6.3 5.3 4.3 3.5 Per Share Data (`) EPS (Basic) 13.6 22.8 29.2 40.2 47.3 EPS (fully diluted) 13.6 22.8 29.2 40.2 47.3 Cash EPS 25.5 38.9 49.4 66.1 77.8 DPS 3.0 4.0 4.0 5.2 6.1 Book Value 114.3 133.4 158.1 192.0 231.9 Returns (%) ROCE 16.1 20.3 22.7 26.9 26.2 Angel ROIC (Pre-tax) 25.8 30.5 35.5 42.5 44.8 ROE 11.9 17.1 18.5 21.0 20.4 Turnover ratios (x) Asset Turnover (Gross Block) 2.6 3.1 3.2 3.6 3.8 Inventory / Sales (days) 89 85 85 85 85 Receivables (days) 61 72 72 72 72 Payables (days) 101 115 115 110 110 WC cycle (ex-cash) (days) 48 42 42 47 47 Source: Company, Angel Research October 26, 2018 7

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER: Reduce (-5% to -15%) Sell (< -15%) Angel Broking Limited (hereinafter referred to as Ratings Angel ) (Based is a registered on Expected Member Returns: of National Buy Stock (> Exchange 15%) of India Limited, Bombay Stock Exchange Limited, Metropolitan Stock Exchange Limited, Multi Commodity Accumulate Exchange (5% to 15%) of India Ltd and National Commodity & Derivatives Exchange Ltd It is also registered as over a Depository 12 months Participant investment with CDSL period) and Portfolio Manager and Investment Reduce Adviser (-5% with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel to -15%) Broking Limited is a registered entity with SEBI Sell for Research (< - Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration 15%) number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, if any The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Disclosure of Interest Statement GMM Pfaudler 1. Financial interest of research analyst or Angel or his Associate or his relative No 2. Ownership of 1% or more of the stock by research analyst or Angel or associates or No relatives 3. Served as an officer, director or employee of the company covered under Research No 4. Broking relationship with company covered under Research No Ratings (Based on Expected Returns: Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) over 12 months investment period) Reduce (-5% to -15%) Sell (< -15%) October 26, 2018 8